The most commonly reported flu-like manifestations include: Nausea and general malaise the most frequent side effect, with incidence varying by product and dose (ranging from approximately 15-40% depending on the specific medication and dosage) Fatigue and low energy levels often described as feeling generally unwell or 'run down' Headaches ranging from mild to moderate intensity Dizziness or light-headedness particularly when standing up quickly, which may reflect dehydration or, in patients also taking insulin or sulfonylureas, possible hypoglycaemia Loss of appetite which, whilst therapeutically beneficial, can contribute to feeling unwell Mild gastrointestinal upset including occasional vomiting or abdominal discomfort These symptoms typically emerge because GLP-1 medications significantly alter gastrointestinal function and metabolic processes
There is interest in using the peptide to induce anabolism in catabolic conditions (e.g
Optum Rx aims for 100% rebate pass-through by 2028
Clinical trials emphasize that the efficacy of GHRP-6 is highly dependent on timing (administration on an empty stomach) and consistency in dosing to maintain pulsatile rhythms
These include: Lack of efficacy: Despite the medications effectiveness for many individuals, it may not produce the desired blood sugar control or weight loss in some cases
Nn c th cng sn xut nhiu th tnh trng lo ha da cng c ngn nga
